Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
Phase 3
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: Voreta plus SunnyD PRODrug: VoretaDrug: Oral Hypoglycemic Agents,Oral
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- Scotmann Pharmaceuticals
- Target Recruit Count
- 340
- Registration Number
- NCT05417880
- Locations
- π΅π°
University of Health Sciences, Lahore, Punjab, Pakistan
Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2021-11-18
- Lead Sponsor
- Scotmann Pharmaceuticals
- Target Recruit Count
- 500
- Registration Number
- NCT05104918
Comparative Pharmacokinetics of Two Different Oral Delivery Systems of Cholecalciferol
Phase 2
- Conditions
- Vitamin D Deficiency
- Interventions
- Dietary Supplement: SunnyD STAT softgel capsuleDrug: SunnyD insta ampouleDietary Supplement: Placebo SunnyD STAT softgel capsuleDrug: Placebo SunnyD insta ampoule
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2022-05-26
- Lead Sponsor
- Scotmann Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT05104970
Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- Scotmann Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT05088928
- Locations
- π΅π°
Rawalpindi Medical University, Rawalpindi, Punjab, Pakistan
Β© Copyright 2025. All Rights Reserved by MedPath